System and method to monitor and titrate treatment for high altitude-induced central sleep apnea (csa)
AssigneeKoninklijke Philips N.V.
InventorBenjamin Irwin SHELLY
Life of this patent
Estimating the term…
Loading patent…
AssigneeKoninklijke Philips N.V.
InventorBenjamin Irwin SHELLY
Estimating the term…
An apparatus and method for employing data from the person and from the environment where the person is situated facilitate the detection and prediction of severity of high altitude-induced Sleep Disordered Breathing (SDB, and specifically Central Sleep Apnea (CSA)). Longitudinal tracking of local barometric pressure and severity of SDB symptoms (objective or subjective or both) allow for prediction of occurrence of SDB (per altitude). Some of all of the data can be obtained from one or more wearable devices that may be worn by the person. Additionally, personalized mapping for dosing of medication (e.g. acetazolamide, low-flow oxygen therapy) to treat high altitude-induced SDB are provided, with recommended dosing provided to the person per altitude.
A method of modeling altitude-induced Central Sleep Apnea (CSA) in a person, comprising:
A method of determining dosage of an altitude-induced Central Sleep Apnea (CSA) treatment for a person, comprising:
An apparatus structured to determine dosage of an altitude-induced Central Sleep Apnea (CSA) treatment for a person, comprising:
Dependencies are inferred from the claim text.